04/2020: UGA Biopharma´s high-speed cell line development workflow

The UGA Biopharma GmbH high-speed workflow was established as an improved cell line development workflow that guarantees CHO cell line development on a shortened time scale.

This innovative offering is based on UGA’s well-established platform technologies including their proprietary CHO host cell lines, system-optimized expression vectors and proprietary high-performance First CHOice® media and feeds, along with a workflow methodology benefiting from experiences and capabilities that UGA Biopharma has gained over the course of many successful international development projects.

For more information, please click here


UGA Biopharma GmbH
Neuendorfstraße 20a
16761 Hennigsdorf
E-mail:  info@ugabiopharma.com This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone: +49(0)3302 / 2024900